Description
THIS REPORT:
Description
The Merger and Acquisition Agreements in Pharma, Biotech and Diagnostics report provides comprehensive understanding and unprecedented access to the merger and acquisition (M&A) agreements entered int...(more)
Description
Key Trends in Drug-Diagnostic Co-Development
Identifying collaborative opportunities and navigating regulatory challenges
Report Overview
The development of genomics-based ...(more)
Description
STUDY OVERVIEW
Today's market driven environment has made performance assessment of managed market account executives complex and critical. Best Practices, LLC has conducted this in-depth stud...(more)
Description
REPORT HIGHLIGHTS
Description
The Manufacturing and Supply Agreements in Pharma, Biotech and Diagnostics, 2nd edition report provides comprehensive understanding and unprecedented access to the manufacturing and supply agreements ...(more)
Description
REPORT HIGHTLIGHTS
Description
The Oncology Partnering Agreements in Pharma, Biotech and Diagnostics report provides comprehensive understanding and unprecedented access to the oncology partnering agreements entered into by the wor...(more)
Description
The report provides a detailed understand and analysis of how and why companies enter co-promotion and co-marketing deals. The majority of deals are multicomponent whereby the licensor retains either ...(more)
Description
In BMI’s updated Business Environment Rankings (BER) for Q109, Peru has slipped from second-last tolast position in the Americas matrix, thus remaining one of the least attractive pharmaceutical...(more)
Description
This benchmark research study assessed Marketing Staffing and Activity versus growth and margin rates across three segments - Branded Bio-Pharma Rx Products, Medical Devices, and Generic Products.
...(more)
Description
Introduction
This databook provides insight into the top 10 companies in the US life sciences industry in terms of their estimated IT spend.
Scope
Description
This report analyzes the global market for Cancer Therapies in US$ Billion. The specific product segments analyzed are Chemotherapy, Targeted Therapy, Hormonal Therapy, and Immunotherapy. Annual forec...(more)
Description
Details the disease states that lead to memory & cognition impairment
Provides forecasts and detail relative to the products available to treat this condition.
Provides definition and ma...(more)
Description
BMI calculates Germany’s pharmaceutical expenditure to have been EUR37.3bn (US$55.0bn) in 2008.By 2013, we expect the total amount spent on prescription and OTC medicines to have reached a value...(more)
Description
The Chinese Hospital Pharmaceutical Market Outlook to 2014’ provides comprehensive coverage of the Chinese pharmaceutical market, reviewing the market structure, pricing and regulation, and incl...(more)
Description
Glaucoma is a type of disease that causes an irreversible blindness, if it is left undetected or untreated. Moreover there is no cure for glaucoma and regular medication is the only way to prevent bli...(more)
Description
BMI forecasts a negative US dollar value growth between 2009 and 2013 for Venezuela’s drug market,due to the expected economic difficulties in 2009 and 2010. In local currency terms, the market ...(more)
Description
Spain’s pharmaceutical market, valued at EUR15.3bn in 2008, is expected to be cushioned from theimpact of the global financial crisis in the short term, with BMI forecasting nominal drug markete...(more)
Description
The Philippines remains ranked as the 11th most attractive pharmaceutical market among 15 majorcountries in the Asia Pacific region, according to BMI’s Business Environment Rankings for Q309.Nev...(more)
Description
Italian economy is one of the most vulnerable economies in an already shaky eurozone. High public debt,poor infrastructure, and a lack of competitiveness are the basis for the likelihood that the coun...(more)
Description
Smoking is the leading cause of preventable death in the world. The effects of smoking represent a global pandemic of enormous proportions. Currently-marketed smoking cessation aids typically lack hig...(more)
Description
South Korea boasts a large pharmaceutical market, with its 2008 value estimated at over US$10.5bn atconsumer prices. However, while the country’s prospects are considerable, price cuts, patent e...(more)
Description
The US is the largest and most important pharmaceutical market in the world. In 2007, total drug expenditure reached US$307.7bn, with per-capita expenditure reaching US$1,022.6. BMI forecasts that the...(more)
Description This report comprises defined and up to date development strategies for 409 protein kinase drugs (990 projects) within the portfolio of 160 investigators, from Ceased to Marketed. The report extens...(more)
Description
In BMI’s Business Environment Ratings for Q409, Spain remains placed fourth out of the nine WesternEuropean Markets surveyed. Spain’s large and generously subsidised drug market, low gener...(more)
© Copyright 1995-2009 Pharmalicensing, a division of UTEK Europe Ltd 
All rights reserved. Terms and Conditions | Contact us
